Published in Cytotherapy on January 01, 2004
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood (2009) 3.62
Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med (2012) 3.39
Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol (2011) 2.34
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant (2006) 2.29
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood (2007) 2.16
Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood (2011) 2.12
Ex vivo expansion of cord blood. Bone Marrow Transplant (2009) 1.46
Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest (2005) 1.43
Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy (2009) 1.35
Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture. Transfusion (2008) 1.10
CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields. Bone Marrow Transplant (2009) 1.03
Advances in umbilical cord blood manipulation-from niche to bedside. Nat Rev Clin Oncol (2014) 0.99
Overcoming the barriers to umbilical cord blood transplantation. Cytotherapy (2010) 0.96
Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Res (2011) 0.96
Umbilical cord blood research: current and future perspectives. Cell Transplant (2007) 0.94
Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease. Front Oncol (2011) 0.91
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells. Stem Cells (2009) 0.89
Minireview: complexity of hematopoietic stem cell regulation in the bone marrow microenvironment. Mol Endocrinol (2014) 0.86
Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine. Stem Cells Transl Med (2013) 0.85
Mesenchymal stem cells in ex vivo cord blood expansion. Best Pract Res Clin Haematol (2011) 0.85
Hematopoietic stem cell expansion and gene therapy. Cytotherapy (2011) 0.83
Cellular complexity of the bone marrow hematopoietic stem cell niche. Calcif Tissue Int (2013) 0.80
Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion. Cytotherapy (2012) 0.79
Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells. Stem Cells Dev (2012) 0.79
Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes? Leukemia (2014) 0.79
The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis. Cancer Med (2015) 0.78
Mesenchymal Stem Cell-Derived Microvesicles Support Ex Vivo Expansion of Cord Blood-Derived CD34(+) Cells. Stem Cells Int (2016) 0.78
Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD. PLoS One (2016) 0.77
Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models. PLoS One (2012) 0.77
The Important Role of FLT3-L in Ex Vivo Expansion of Hematopoietic Stem Cells following Co-Culture with Mesenchymal Stem Cells. Cell J (2015) 0.76
Umbilical cord matrix derived mesenchymal stem cells can change the cord blood transplant scenario. Int J Stem Cells (2010) 0.75
Human adipose-tissue derived stromal cells in combination with hypoxia effectively support ex vivo expansion of cord blood haematopoietic progenitors. PLoS One (2015) 0.75
Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood. Acta Naturae (2016) 0.75
Multiplacenta derived stem cell/cytokine treatment increases survival time in a mouse model with radiation-induced bone marrow damage. Cytotechnology (2016) 0.75
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells). PLoS One (2017) 0.75
Lagging strand DNA synthesis at the eukaryotic replication fork involves binding and stimulation of FEN-1 by proliferating cell nuclear antigen. J Biol Chem (1995) 2.80
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant (2006) 2.29
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 2.10
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy (2005) 1.70
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
Absence of myosin-like immunoreactivity in stereocilia of cochlear hair cells. Nature (1982) 1.62
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.48
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea. Clin Cancer Res (1999) 1.43
Effects of age, size and condition of elephant seals (Mirounga leonina) on their intravenous anaesthesia with tiletamine and zolazepam. Vet Rec (2002) 1.42
Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone. Hum Pathol (1994) 1.41
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst (1993) 1.40
Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest (1996) 1.40
Acute encephalopathy: a new toxicity associated with high-dose paclitaxel. Clin Cancer Res (1999) 1.40
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol (1988) 1.40
Dissemination and commercialization of hematopoietic progenitor cell transplantation. J Hematother (1994) 1.39
Suxamethonium in bunged cannulae. Anaesth Intensive Care (1992) 1.39
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplant (2009) 1.27
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant (2006) 1.23
Floppy eyelid syndrome. Management including surgery. Ophthalmology (1986) 1.22
Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood (1997) 1.21
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. Leukemia (2007) 1.20
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy (2004) 1.10
Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol (2000) 1.10
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood (2000) 1.07
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity. Cytotherapy (2006) 1.06
Invasive pneumococcal infections among Canadian aboriginal children. Can Commun Dis Rep (2003) 1.05
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant. Leukemia (2013) 1.05
CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields. Bone Marrow Transplant (2009) 1.03
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood (1997) 1.02
Social diversity of Irish adults nutritional intake. Eur J Clin Nutr (2003) 1.02
An examination of the relationship between visual capture and prism adaptation. Percept Psychophys (1979) 1.02
Individual risk factors for early repetition of deliberate self-harm. Br J Med Psychol (1997) 1.01
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant (2007) 1.01
Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer (2007) 0.99
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant (2010) 0.97
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. Bone Marrow Transplant (2000) 0.96
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplant (2006) 0.96
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. J Clin Oncol (1999) 0.96
Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol (2010) 0.95
Reading aloud begins when the computation of phonology is complete. J Exp Psychol Hum Percept Perform (2000) 0.94
Release of tumor cells from bone marrow. Blood (1994) 0.93
Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals. Biol Blood Marrow Transplant (1999) 0.93
Acoustic evidence for dynamic formant trajectories in Australian English vowels. J Acoust Soc Am (1999) 0.93
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant. Clin Cancer Res (1999) 0.92
High-dose chemotherapy for the treatment of breast and ovarian cancer. Curr Opin Oncol (1997) 0.92
Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment. Hypertension (1991) 0.92
The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer. Cancer (1990) 0.92
Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene (2012) 0.91
Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int (1996) 0.91
Asthma severity and morbidity in a population sample of Sydney school children: Part I--Prevalence and effect of air pollutants in coastal regions. Aust N Z J Med (1994) 0.91
Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck. Arch Otolaryngol Head Neck Surg (1995) 0.90
High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes. Bone Marrow Transplant (1997) 0.89
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype. Leukemia (2010) 0.89
Effective utilization of erythropoietin with intravenous iron therapy. J Clin Pharm Ther (1998) 0.89
Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. J Natl Cancer Inst (1993) 0.89
Symptomatic bipartite sesamoids. J Foot Surg (1990) 0.89
Pre-diabetes in adults 45 years and over in Ireland: the Survey of Lifestyle, Attitudes and Nutrition in Ireland 2007. Diabet Med (2013) 0.88
PET imaging of T cells derived from umbilical cord blood. Leukemia (2008) 0.88
Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res (1989) 0.88
HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance. Leukemia (2011) 0.87
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia. Bone Marrow Transplant (2012) 0.87
Surface activity of hemoglobin S and other human hemoglobin variants. Biochim Biophys Acta (1976) 0.87
Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood (1996) 0.87
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.87
High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer. Semin Oncol (1996) 0.87
Management of acquired rectourinary fistulas: outcome according to cause. Dis Colon Rectum (1998) 0.87
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol (2000) 0.86
Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer. Int J Cancer (1991) 0.86
HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells. Apoptosis (1997) 0.85
In vitro growth of neonatal rat islet cells is stimulated by adhesion to matrix. Horm Metab Res (1995) 0.85
Breakdown of the round window membrane permeability barrier evoked by streptolysin O: possible etiologic role in development of sensorineural hearing loss in acute otitis media. Infect Immun (1995) 0.85
The impact of a workplace catering initiative on dietary intakes of salt and other nutrients: a pilot study. Public Health Nutr (2011) 0.84
Hyperkalaemia in cyclosporin-treated renal allograft recipients. Lancet (1983) 0.84
Mobilization and selection of CD34-positive hematopoietic progenitors. Blood Rev (1996) 0.84
The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in man. Haemostasis (1981) 0.84
Myocardial ischemia associated with high-dose carmustine infusion. Cancer (1991) 0.84
Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells. Breast Cancer Res Treat (1996) 0.83
Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells. Biol Blood Marrow Transplant (1997) 0.83
Significance of individual point mutations, T202C and C314T, in the human Lewis (FUT3) gene for expression of Lewis antigens by the human alpha(1,3/1,4)-fucosyltransferase, Fuc-TIII. J Biol Chem (1997) 0.82
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer. J Clin Oncol (1998) 0.82
[New possibilities in oral immunoprophylaxis of newborn diarrhea in calves--a field study using specific egg antibodies]. Berl Munch Tierarztl Wochenschr (1993) 0.82
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study. Cancer Chemother Pharmacol (1989) 0.82
Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. Biol Blood Marrow Transplant (2000) 0.82
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT. Bone Marrow Transplant (2008) 0.81
Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Bone Marrow Transplant (2005) 0.81
Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model. J Hematother (1998) 0.81
Bronchial hyperreactivity is correlated with increased baseline airway tone. Eur J Med Res (2006) 0.81
Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia. Bone Marrow Transplant (2000) 0.80
A pilot study of the relationship between problem-solving skills and outcome in major depressive disorder. Br J Med Psychol (2000) 0.80
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies. Cancer Chemother Pharmacol (1996) 0.80
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Exp Hematol (1997) 0.80
Insulin secretion and DNA synthesis of cultured islets of Langerhans are influenced by the matrix. Pancreas (1995) 0.80
Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer. Breast Cancer Res Treat (1993) 0.80
Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Transpl Infect Dis (2007) 0.79
Oto-Palato-Digital syndrome with severe X-ray changes in two half brothers. Pediatr Radiol (1977) 0.79
The potential of a store and forward tele-behavioral platform for effective treatment and research of autism. Conf Proc IEEE Eng Med Biol Soc (2004) 0.79